468 related articles for article (PubMed ID: 22900535)
1. Glutathione levels in human tumors.
Gamcsik MP; Kasibhatla MS; Teeter SD; Colvin OM
Biomarkers; 2012 Dec; 17(8):671-91. PubMed ID: 22900535
[TBL] [Abstract][Full Text] [Related]
2. Metallothionein - immunohistochemical cancer biomarker: a meta-analysis.
Gumulec J; Raudenska M; Adam V; Kizek R; Masarik M
PLoS One; 2014; 9(1):e85346. PubMed ID: 24416395
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of altered blood and tissue glutathione levels in head and neck squamous cell carcinoma cases.
Khan SU; Mahjabeen I; Malik FA; Kayani MA
Asian Pac J Cancer Prev; 2014; 15(18):7603-9. PubMed ID: 25292035
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
Hierro C; Rodon J; Tabernero J
Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
[TBL] [Abstract][Full Text] [Related]
5. Development and Validation of an ERCC1 Immunohistochemistry Assay for Solid Tumors.
Bahamon BN; Gao F; Danaee H
Arch Pathol Lab Med; 2016 Dec; 140(12):1397-1403. PubMed ID: 27610644
[TBL] [Abstract][Full Text] [Related]
6. Cancer Antigen 72-4 for the Monitoring of Advanced Tumors of the Gastrointestinal Tract, Lung, Breast and Ovaries.
Mariampillai AI; Cruz JPD; Suh J; Sivapiragasam A; Nevins K; Hindenburg AA
Anticancer Res; 2017 Jul; 37(7):3649-3656. PubMed ID: 28668856
[TBL] [Abstract][Full Text] [Related]
7. Nestin in gastrointestinal and other cancers: effects on cells and tumor angiogenesis.
Ishiwata T; Matsuda Y; Naito Z
World J Gastroenterol; 2011 Jan; 17(4):409-18. PubMed ID: 21274370
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining.
Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C
Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987
[TBL] [Abstract][Full Text] [Related]
9. Importance of comorbidity in head and neck cancer.
Piccirillo JF
Laryngoscope; 2000 Apr; 110(4):593-602. PubMed ID: 10764003
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas.
Routhier CA; Mochel MC; Lynch K; Dias-Santagata D; Louis DN; Hoang MP
Hum Pathol; 2013 Nov; 44(11):2563-70. PubMed ID: 24071017
[TBL] [Abstract][Full Text] [Related]
11. Current concepts in the diagnosis and pathobiology of intraepithelial neoplasia: A review by organ system.
Voltaggio L; Cimino-Mathews A; Bishop JA; Argani P; Cuda JD; Epstein JI; Hruban RH; Netto GJ; Stoler MH; Taube JM; Vang R; Westra WH; Montgomery EA
CA Cancer J Clin; 2016 Sep; 66(5):408-36. PubMed ID: 27270763
[TBL] [Abstract][Full Text] [Related]
12. Pathological Significance and Prognostic Value of Surfactant Protein D in Cancer.
Mangogna A; Belmonte B; Agostinis C; Ricci G; Gulino A; Ferrara I; Zanconati F; Tripodo C; Romano F; Kishore U; Bulla R
Front Immunol; 2018; 9():1748. PubMed ID: 30127783
[TBL] [Abstract][Full Text] [Related]
13. Positron emission tomography with 2-[18F]fluoro-2-deoxy-D-glucose in oncology. Part II. The clinical value in detecting and staging primary tumours.
Ak I; Stokkel MP; Pauwels EK
J Cancer Res Clin Oncol; 2000 Oct; 126(10):560-74. PubMed ID: 11043393
[TBL] [Abstract][Full Text] [Related]
14. Cancer/testis antigen CT45: analysis of mRNA and protein expression in human cancer.
Chen YT; Hsu M; Lee P; Shin SJ; Mhawech-Fauceglia P; Odunsi K; Altorki NK; Song CJ; Jin BQ; Simpson AJ; Old LJ
Int J Cancer; 2009 Jun; 124(12):2893-8. PubMed ID: 19296537
[TBL] [Abstract][Full Text] [Related]
15. LAPTM4B overexpression is a novel independent prognostic marker for metastatic ovarian tumors.
Yin M; Lou C; Zhang W; Meng F; Zhang H; Ning X; Zhou R; Dong X; Lou G
Int J Gynecol Cancer; 2012 Jan; 22(1):54-62. PubMed ID: 22193644
[TBL] [Abstract][Full Text] [Related]
16. Visualization of GFP-expressing tumors and metastasis in vivo.
Hoffman RM
Biotechniques; 2001 May; 30(5):1016-22, 1024-6. PubMed ID: 11355337
[TBL] [Abstract][Full Text] [Related]
17. ROBO1 Expression in Metastasizing Breast and Ovarian Cancer: SLIT2-induced Chemotaxis Requires Heparan Sulfates (Heparin).
Rezniczek GA; Grunwald C; Hilal Z; Scheich J; Reifenberger G; Tannapfel A; Tempfer CB
Anticancer Res; 2019 Mar; 39(3):1267-1273. PubMed ID: 30842157
[TBL] [Abstract][Full Text] [Related]
18. Lymphatic mapping and sentinel node analysis: current concepts and applications.
Chen SL; Iddings DM; Scheri RP; Bilchik AJ
CA Cancer J Clin; 2006; 56(5):292-309; quiz 316-7. PubMed ID: 17005598
[TBL] [Abstract][Full Text] [Related]
19. Utility of serum activity of angiotensin-converting enzyme as a tumor marker.
Varela AS; Bosco Lopez Saez JJ
Oncology; 1993; 50(6):430-5. PubMed ID: 8233282
[TBL] [Abstract][Full Text] [Related]
20. G-protein coupled receptor-associated sorting protein 1 (GASP-1), a ubiquitous tumor marker.
Zheng X; Chang F; Zhang X; Rothman VL; Tuszynski GP
Exp Mol Pathol; 2012 Aug; 93(1):111-5. PubMed ID: 22483848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
